![David Tierney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Tierney
Chief Executive Officer at
Aramis Biosciences, Inc.
Profile
David S.
Tierney was the founder of Oceana Therapeutics, Inc., founded in 2008, where the titles held included President, Chief Operating Officer & Director in 2011.
Current jobs include President, CEO, Secretary, Treasurer & Director at Aramis Biosciences, Inc., and Director at Bimeda, Inc. since 2018.
Former jobs include President, Chief Executive Officer & Director at Valera Pharmaceuticals, Inc. from 2000 to 2007; President & Chief Executive Officer at Icon Bioscience, Inc. from 2014 to 2018; Chief Executive Officer at Pharma Two B Ltd. from 2020 to 2021; President & Chief Executive Officer at BioPharmX Corp.
from 2019 to 2020; Director at Bioject Medical Technologies, Inc.; Director at Able Laboratories, Inc.; Director at Apricus Biosciences, Inc. from 2007 to 2009; Medical Director at Elan Pharmaceuticals LLC from 1989 to 1997; Director at Viatar CTC Solutions, Inc.; Director at Palvella Therapeutics, Inc.; Independent Director at Zevra Therapeutics, Inc.; Independent Director at Catalyst Pharmaceuticals, Inc. from 2011 to 2026; Senior Vice President-Drug Development at Roberts Pharmaceutical Corp.
from 1997 to 2000; Venture Partner at Signet Healthcare Partners LLC from 2013 to 2014; and President at Biovail Technologies Ltd. in 2000.
Education includes a doctorate conferred in 1987 from the Royal College of Surgeons.
David Tierney active positions
| Companies | Position | Start |
|---|---|---|
Bimeda, Inc.
 Bimeda, Inc. Pharmaceuticals: MajorHealth Technology Manufactures veterinary pharmaceuticals and animal health care products | Director/Board Member | 01/06/2018 |
Aramis Biosciences, Inc.
 Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunology and ophthalmology biopharmaceuticals | Chief Executive Officer | - |
Former positions of David Tierney
| Companies | Position | End |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Director/Board Member | 15/07/2026 |
Pharma Two B Ltd.
 Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Develops combination drugs for neurological disorders | Chief Executive Officer | 01/01/2021 |
| TREX WIND-DOWN, INC. | Chief Executive Officer | 01/01/2020 |
Icon Bioscience, Inc.
 Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Chief Executive Officer | 01/03/2018 |
Signet Healthcare Partners LLC
 Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners invests in public and private companies across the globe. The fund targets companies operating in the fields of generic & specialty pharmaceuticals, pharmaceuticals services, medical devices and diagnostics. It provides financing for later and growth stage capital requirements with an investment size of USD 10 - 15 million. It makes co-investments and acts as lead investor with majority and minority investments. It also takes a seat on the board of directors. | Corporate Officer/Principal | 01/03/2014 |
Training of David Tierney
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
19
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Bioject Medical Technologies, Inc.
 Bioject Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures needle-free injection therapy systems | Health Technology |
Roberts Pharmaceutical Corp.
 Roberts Pharmaceutical Corp. Pharmaceuticals: OtherHealth Technology Provides pharmaceutical products | Health Technology |
Able Laboratories, Inc.
 Able Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Health Technology |
Valera Pharmaceuticals, Inc.
 Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders | Health Technology |
Signet Healthcare Partners LLC
Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners invests in public and private companies across the globe. The fund targets companies operating in the fields of generic & specialty pharmaceuticals, pharmaceuticals services, medical devices and diagnostics. It provides financing for later and growth stage capital requirements with an investment size of USD 10 - 15 million. It makes co-investments and acts as lead investor with majority and minority investments. It also takes a seat on the board of directors. | Finance |
Catalyst Pharmaceuticals, Inc.
 Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Icon Bioscience, Inc.
Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
Viatar CTC Solutions, Inc.
 Viatar CTC Solutions, Inc. Medical SpecialtiesHealth Technology Develops and markets products to collect cancer cells for molecular diagnostics | Health Technology |
Bimeda, Inc.
Bimeda, Inc. Pharmaceuticals: MajorHealth Technology Manufactures veterinary pharmaceuticals and animal health care products | Health Technology |
Royal College of Surgeons
 Royal College of Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biovail Technologies Ltd.
 Biovail Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bausch Health Cos., Inc., Biovail Technologies Ltd. is a company that operates in the Information & Document Management industry. The company is based in Chantilly, VA. | Commercial Services |
Oceana Therapeutics, Inc.
 Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and medical devices | Health Technology |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Develops combination drugs for neurological disorders | Health Technology |
BioPharmX Corp.
 BioPharmX Corp. BiotechnologyHealth Technology Develops drug-delivery products | Health Technology |
Palvella Therapeutics, Inc.
 Palvella Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing new therapeutic agents for diseases suffered by patients that lack any treatment choices | Health Technology |
Aramis Biosciences, Inc.
Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunology and ophthalmology biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- David Tierney
